Angioplasty, percutaneous transluminal

Ueda T, Hatakeyama T, Kohno K, Kumon Y, Sakaki S. Endovascular treatment for acute thrombotic occlusion of the middle cerebral artery local intra-arterial thrombolysis combined with percutaneous transluminal angioplasty. Neuroradiology 1997 39 99-104. 

Nakano S, Iseda T, Yoneyama T, Kawano H, Wakisaka S. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion an alternative option to intra-arterial thrombolysis. Stroke 2002 33 2872-2876. 

Vascular stenting has become a common procedure during percutaneous transluminal angioplasty (PTA) and percutaneous transluminal coronary angioplasty (PTCA) procedures because it has been found to reduce restenosis (Narins et al., 1998). In both the STRESS (Stent Restenosis Study) and BENESTENT... 

Mathias K. [A new catheter system for percutaneous transluminal angioplasty (PTA) of carotid artery stenoses]. Fortschr Med 1977 95 1007-101 I. 

Belan A, Vesela M, Vanek I, Weiss K, Peregrin JH. Percutaneous transluminal angioplasty of fibromuscular dysplasia of the internal carotid artery. Cardiovasc Intervent Radiol 1982 5 79-81. 

Bockenheimer SA, Mathias K. Percutaneous transluminal angioplasty in arteriosclerotic internal carotid artery stenosis. AJNRAmJ Neuroradiol 1983 4 791-792. 

HassoAN, Bird CR, Zinke DE, Thompson JR. Fibromuscular dysplasia of the internal carotid artery percutaneous transluminal angioplasty. AJR Am J Roentgenol 1981 136 955-960. 

Tsai FY Matovich V Hieshima G, et al. Percutaneous transluminal angioplasty of the carotid artery. AJNRAmJ Neuroradiol 1986 7 349-358. 

Guimaraens L, Sola MT Matali A, et al. Carotid angioplasty with cerebral protection and stenting report of 164 patients (194 carotid percutaneous transluminal angioplasties). Cerebrovasc Dis 2002 13 1 14-1 19. 

Post laser atherectomy and percutaneous transluminal angioplasty of popliteal artery as well as tibioperoneal trunk, IV heparin used as an anticoagulant with pretreatment with aspirin and clopidogreh... 

Coward LJ, Featherstone RL, Brown MM (2005). Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis. Cochrane Database of Systemic Reviews 2 CD000516... 

Weernink, E.E.M., Huisman, A.B., van Baarlen, J., ten Napel, C.H.H. Treatment of the Budd-Chiari syndrome by insertion of a wall-stent in the hepatic vein after percutaneous transluminal angioplasty the necessity of follow-up. Eur. X Gastroenterol. Hepatol. 1996 8 85-88... 

Ten patients with peripheral arterial occlusive disease were scheduled to undergo elective percutaneous transluminal angioplasty after a single dose of ciprofloxacin 400 mg (66). Antibiotic concentrations were significantly reduced in ischemic lesions compared with healthy adipose tissue. However, improvement of arterial blood flow in the affected limb was associated with increased cure rates of soft tissue infections. 

For obvious reasons, the use of dopamine may be dangerous in cases of coronary or peripheral vascular disorders. Dopamine used for hypotension during percutaneous transluminal angioplasty (PTCA) can be associated with diffuse coronary spasm, and it should therefore be used with caution, particularly if high doses are required. When dopamine aggravates pulmonary hypertension and right ventricular failure, isoprenaline should be considered as an alternative inotropic drug. 

Percutaneous transluminal angioplasty (PTCA) and coronary artery bypass grafting (CABG) produce similar results overall, but certain patient subsets (e.g., diabetics) should have CABG done. 

The response-to-injury hypothesis states that risk factors such as oxidized LDL, mechanical injury to the endothelium (e.g., percutaneous transluminal angioplasty), excessive homocysteine, immunologic attack, or infection-induced (e.g.. Chlamydia, herpes simplex virus 1) changes in endothelial and intimal function lead to endothelial dysfunction and a series of cellular interactions that culminate in atherosclerosis. C-reactive protein (CRP) is an acute-phase reactant and a marker for inflammation it may be useful in identifying patients at risk for developing CAD. The eventual outcomes of this atherogenic cascade are clinical events such as angina, MI, arrhythmias. 

Percutaneous transluminal angioplasty (PTA) is an example of an invasive treatment for PAD. A randomized controlled clinical trial performed by Whyman and colleagues determined that in a 2 years postintervention, the PTA outcomes on maximum walking distance and ABI were not significantly different than in patients that had only received daily low-dose ASA (p >0.05)." Nevertheless, patients who had received PTA had significantly fewer occluded arteries (p = 0.003), but the true clinical significance of this finding was not able to be realized in the time allotted for the study. 

PTA percutaneous transluminal angioplasty STIMS Swedish Ticlopidine Multicenter Study TASC TransAtlantic Inter-Society Consensus TLC therapeutic lifestyle changes... 

Whyman MR, Fowkes FG, Kerracher EM, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty A randomized controlled trial. JVasc Surg 1997 26 551-557. 

Bosch J, Hunink M. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease (published erratum appears in Radiology 1997 Nov 205[2] 584). Radiology 1997 204 87-96. 

Percutaneous transluminal angioplasty or balloon dilation of the coronary artery results in a dramatic clinical response in many patients. Long-term benefit, however, is dependent on the progression of the disease at the dilated site °. The factors which determine the rate of progression of the disease or the development of acute coronary occlusion are not known but pathological evidence of severe trauma with deposition of platelets and endothelial loss at the angioplasty site suggest that eicosanoids may be important . ... 

The treatment of venous stenosis and SVCS caused by intravenously inserted leads depends on the site of venous obstruction, duration, and symptoms. Acute presentation with severe symptoms suggests prompt treatment with thrombolytics and maybe percutaneous transluminal angioplasty, which improves short-term results. Long term results show that anticoagulation with heparin and warfarin leads to similar clinical outcomes, and there is some debate as to whether to give prophylactic anticoagulation therapy in high-risk patients or not. 

PTCA Percutaneous transluminal coronary angioplasty, PTA Percutaneous transluminal angioplasty TIPS Transjugular intrahepatic portosystemic shunt. 

Uflaker R, Francisconi CF, Rodriguez MP et al. (1984) Percutaneous transluminal angioplasty of the hepatic veins for treatment of Budd-Chiari syndrome. Radiology 153 641-642... 

Labropoulos N, Volteas N, Giannoukas A, Kutoubi A Al, Wolfe J, Mansfield AO, Nicolaides AN. Early hemodynamic effects of percutaneous transluminal angioplasty in patients with superficial femoral artery disease. Vase Surg 1997 31 615-621. 

Hagenaars T, Gussenhoven EJ, van Sambeek MR, Jukema JW, Kranendonk SE, Bom N. Effect of simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction. Am J Cardiol 2000 86 114-116. 

Pentecost MJ, Criqui MH, Dorros G, et. al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. Circulation 1994 89 511-531. 

---